(Q58834607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

J F Robertson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P C Willsher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R W Blamey

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1774-1779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900178-0

7 January 2021

The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900178-0

7 January 2021

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900178-0

7 January 2021

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900178-0

7 January 2021

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900178-0

7 January 2021

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900178-0

7 January 2021

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900178-0

7 January 2021

10.1016/S0959-8049(97)00178-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470831%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference